Post by HaystackAnalytics

Empirical therapy was designed to buy time. The question is: what happens when buying time becomes the endpoint? As infectious disease diagnostics continue to advance, healthcare systems have an opportunity to move beyond prolonged uncertainty and closer to precise pathogen identification. The future may not be about choosing between empirical and targeted therapy, but reducing the time between the two. Abhimanyuu Nambisan Rohan S SALVI Gitesh Srivastava Vivek Singh Rathore Pranav Godse siddharth sasane Shuja A. Simone Jetha Dr. Simran Malik Dr Koyel Ghosh Dr Mahua Das Gupta (Kapoor) #InfectiousDiseases #PrecisionDiagnostics #ClinicalMicrobiology #NGS #AntimicrobialStewardship #infexn #HealthCare #PublicHealth